A detailed history of Schechter Investment Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Schechter Investment Advisors, LLC holds 33,766 shares of NVO stock, worth $2.95 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
33,766
Previous 33,519 0.74%
Holding current value
$2.95 Million
Previous $4.78 Million 15.97%
% of portfolio
0.4%
Previous 0.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $29,410 - $35,918
247 Added 0.74%
33,766 $4.02 Million
Q2 2024

Aug 12, 2024

BUY
$122.71 - $146.91 $45,034 - $53,915
367 Added 1.11%
33,519 $4.78 Million
Q1 2024

May 06, 2024

BUY
$102.11 - $135.92 $88,120 - $117,298
863 Added 2.67%
33,152 $4.26 Million
Q4 2023

Jan 17, 2024

SELL
$87.78 - $105.45 $86,814 - $104,290
-989 Reduced 2.97%
32,289 $3.34 Million
Q3 2023

Nov 06, 2023

BUY
$90.94 - $199.54 $1.92 Million - $4.22 Million
21,166 Added 174.75%
33,278 $3.03 Million
Q2 2023

Jul 26, 2023

BUY
$155.98 - $172.65 $513,642 - $568,536
3,293 Added 37.34%
12,112 $1.96 Million
Q1 2023

Apr 28, 2023

BUY
$132.34 - $159.14 $3,705 - $4,455
28 Added 0.32%
8,819 $1.4 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $81,937 - $108,128
799 Added 10.0%
8,791 $1.19 Million
Q3 2022

Nov 04, 2022

SELL
$95.28 - $116.93 $96,328 - $118,216
-1,011 Reduced 11.23%
7,992 $796,000
Q2 2022

Nov 03, 2022

BUY
$103.24 - $121.81 $929,469 - $1.1 Million
9,003 New
9,003 $1 Million
Q1 2022

Nov 18, 2022

BUY
$93.1 - $112.54 $8,379 - $10,128
90 Added 1.13%
8,082 $898,000
Q4 2021

Dec 27, 2022

SELL
$95.88 - $117.08 $52,254 - $63,808
-545 Reduced 6.82%
7,447 $834,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Schechter Investment Advisors, LLC Portfolio

Follow Schechter Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schechter Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schechter Investment Advisors, LLC with notifications on news.